Build and maintain scientific relationships with key opinion leaders, clinicians, researchers, and public health stakeholders.
Communicate epidemiological, clinical and real-world data regarding pneumococcal disease and Vaxcyte’s candidate vaccine.
Support investigator-initiated studies and clinical trial recruitment in vaccine research.
Gather and share field insights on pneumococcal disease landscape, vaccine data needs, and recommendation scenarios.
Represent the company at scientific meetings, conferences, and stakeholder events.
Uphold ethical standards and regulatory guidelines in all field activities.
Showing 1 of 2 positions
About Vaxcyte
Vaxcyte is pioneering next-generation vaccines to combat some of the world's deadliest infectious diseases. We are engineering high-fidelity vaccines, like VAX-31 and VAX-24, to prevent invasive pneumococcal disease. Our XpressCF™ cell-free protein synthesis platform allows us to craft superior, novel vaccines. These vaccines aim for broader and more effective protection than current options. With $2.4 billion in cash equivalents by early 2026, we are well-funded for sustained innovation. Our commitment extends to preventing Group A Strep infections and treating periodontal disease. We are transforming global health with every vaccine we develop.
How We Work
Our culture thrives on challenging norms and leading with empathy. We foster an environment where every voice contributes to complex biological solutions. We operate with a kindness-first approach, valuing vigorous debate and inclusive collaboration. Vaxcyte embraces flexibility with a hybrid work schedule and a remote work program. Several roles, including Medical Science Liaisons, are explicitly remote-first. This flexibility allows us to attract and retain top talent across the US. We are guided by core values: Rethink Convention, Aim High, Lead with Heart, and Model Excellence. Our commitment to integrity, accountability, and clarity shapes our decisions.
Engineering at Vaxcyte
Vaxcyte's technical edge comes from our proprietary XpressCF™ cell-free protein synthesis platform. This innovative platform, exclusively licensed from Sutro Biopharma, Inc., is crucial to our vaccine development. It enables the precise design and production of complex protein carriers and antigens. This technology allows us to create vaccines in ways conventional methods cannot. Our scientific teams are constantly pushing the boundaries of what is possible in vaccine engineering. You will contribute to advancing solutions that address significant global health challenges. We leverage a diverse tech stack including Microsoft Azure, Cloudflare, and WP Engine. This infrastructure supports our ambitious research and development goals. Join us to build and deploy advanced biological solutions.
Why Join Us
Contribute to developing next-generation vaccines for global health.
Work with a proprietary, cutting-edge cell-free protein synthesis platform.
Join a well-funded company with over $2.4 billion for sustained innovation.
Thrive in a culture valuing kindness, collaboration, and rethinking convention.
Benefit from a hybrid and remote-friendly work environment.